FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: A report of five cases and review of the literature

Cancer Investigation

Volumn 26, Issue 6, 2008, Pages 610-614

  Berretta, Massimiliano ^a   Di Benedetto, Fabrizio ^b   Bearz, Alessandra ^a   Simonelli, Cecilia ^a   Martellotta, Ferdinando ^a   Del Ben, Chiara ^a   Berretta, Salvatore ^c   Spina, Michele ^a   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Colorectal cancer; FOLFOX 4; HAART; HIV

Indexed keywords

AMPRENAVIR; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; FLUCONAZOLE; FLUOROURACIL; FOLINIC ACID; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; OXALIPLATIN; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COLORECTAL CANCER; COMORBIDITY; FEMALE; GASTROINTESTINAL TOXICITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HIV INFECTIONS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 46349102112     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701781747     Document Type: Article

References (19)

1. Cooley, T.P. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin N Am 2003, 17, 889-899.
2. Levine, A.M. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993, 85, 1382-1397.
3. Wang, C.Y.; Snow, J.L.; Su, W.P. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc 1995, 70, 665-672.
4. Berretta, M.; Cinelli, R.; Martellotta, F.; et al. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003, 22, 6646-6659.
5. Bonnet, F.; Lewden, C.; May, T.; et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004, 101, 317-324.
6. Stewart, W.B.; Kleihues, P. World cancer report 2003 IARC. http://www.iarc.fr/WCR/ Accessed 18 January 2008.
7. Andre, T.; Bensmaine, M.A.; Louvet, C.; et al. Multicenter phase II study of bimonthly high dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 1999, 17, 3560-3568.
8. National Cancer Institute. Common Toxicity Criteria, version 2.0. Bethesda, Maryland, USA: National Cancer Institute, 1999.
9. Saltz, L.B.; Cox, J.V.; Blanke, C.; et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. The Irinotecan Study Group. N Engl J Med 2000, 343, 905-914.
10. Cappell, M.S.; Yao, F.; Cho, K.C. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. Cancer 1988, 62, 616-619.
11. Klugman, A.D.; Schaffner, J. Colon adenocarcinoma in HIV infection: a case report and review. Am J Gastroenterol 1994, 89, 254-256.
12. Yeguez, J.F.; Martinez, S.; Sands, D.; et al. Colorectal malignancies in HIV-positive patients. Am Surg 2003, 11, 981-987.
13. Berretta, M.; Martellotta, F.; Spina, M.; et al. Clinical features and outcome of colorectal cancer in HIV-infected people: a GICAT experience (Abstract). Gastrointestinal Cancer Symposium - Am Soc Clin Oncol GI Meeting, ASCO 2005, Miami, FL, 2005, Abstract 201.
14. Dal Maso, L.; Serraino, D.; Franceschi, S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001, 37, 1188-1201.
15. Serraino, D.; Boschini, A.; Carrieri, P.; et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000, 14, 553-559.
16. Herida, M.; Mary-Krause, M.; Kaphan, R.; et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003, 21, 3447-3453.
17. Appleby, P., Beval, V., Newton, R., Reeves, G., Carpenter, L. International Collaboration on HIV and Cancer: highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000, 92, 1823-1830.
18. Biggar, R.J. AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology 2001, 15, 439-448.
19. Vaccher, E.; Spina, M.; Talamini, R.; et al. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy. Clin Infect Dis 2003, 37, 1556-1564.